Advertisement

Neuroscience Bulletin

, Volume 24, Issue 2, pp 110–116 | Cite as

Migraine as a sex-conditioned inherited disorder: evidences from China and the world

  • Xiao-Ping Wang (王晓平)Email author
  • Hong-Liu Ding (丁洪流)
  • Chang-Ming Geng (耿昌明)
  • Yu-Mei Jiang (蒋玉美)
Minireview

Abstract

Migraine is a complex and heterogeneous disorder. Although several genetic models has been proposed including autosomal-dominant/autosomal recessive, sex-linked, sex-limited, mitochondrial, and multi-gene, none of these models can well-explain the transmission of the disease. We hypothesied that migraine is a sex-conditioned inherited disorder (autosomal dominant in females and autosomal recessive in males). This hypothesis is supported by the evidence such as the locations of genes associated with familial hemiplegic migraine, possibly “typical” migraine as well (dominantly on chromosome 19p, 1q, and 2q), male:female ratio of prevalence (1:2–1:4), the mostly youth-onset, the provocation by the contraceptives, the induction by menstruation, and the self-limitation after menopause. Female sex-hormones appear to be the key contributor to a higher prevalence of migraine in female. Socio-environmental factors may also play an important role.

Keywords

epidemiology genetics migraine familial hemiplegic migraine 

偏头痛是从性性状式遗传疾患? 来自中国以及世界的证据

摘要

偏头痛是一种复杂的多样性疾患. 尽맜此前已提出包括常染色体显性/常染色体隐性, 伴性性状, 限性性状, 线粒体性及多基因性遗传模式, 但均难以很好地解释该病的遗传性. 笔者设想偏头痛为从性性状式(Sex-conditioned)遗传性疾患, 即在男性患者为常染色体隐性遗传, 在女性为常染色体显性遗传. 支持此假设的证据有: 家族性偏瘫性偏头痛以及其它一些经典的偏头痛疾病相关基因位于在常染色体19p, 1q 和2q; 男女性别比为1:2–1:4; 大多数在青年期前后发病; 避孕药可以诱发; 月经期好发; 女性绝经期常自愈. 女性性激素可能是该病在女性中高发的关键因素. 此外, 环境和人文经济因素亦可能具有重要作用.

关键词

流行病学 遗传学 偏头痛 家族性偏瘫性偏头痛 

CLC number

R747.2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Liu ZL, Liang XL. Genetics in Neurology. 1st ed. Beijing: People’s Medical Publishing House, 1988, 249–253. (Chinese)Google Scholar
  2. [2]
    Wang XP, Liu JM, Zhao YB. Migraine: Sex-influenced trait model? Med Hypotheses 2008; doi:10.1016/j.mehy.2007.12.015.Google Scholar
  3. [3]
    Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd ed. Cephalalgia 2004, 24(Supple 1): 9–160.Google Scholar
  4. [4]
    Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol 1995, 24: 612–618.PubMedCrossRefGoogle Scholar
  5. [5]
    Goldstein M, Chen TC. The epidemiology of disabling headache. Adv Neurol 1982, 33: 377–390.PubMedGoogle Scholar
  6. [6]
    Bruyn GW. Epidemiology of migraine ‘a personal view’. Headache 1983, 23: 127–133.PubMedGoogle Scholar
  7. [7]
    Wang WJ. Epidemiology of migraine: investigation report of Chinese countryside and racial area. In: Proceeding of Beijing Neurosurgic Institute and NIH and WHO 1986, 74–101. (Chinese)Google Scholar
  8. [8]
    Gou SS, Xue GB, Wang GQ. Investigation of migraine in the mainland of China. Clin J Neurol 1991, 4: 65–69. (Chinese)Google Scholar
  9. [9]
    Wang SJ, Liu HC, Fuh JL, Liu CY, Lin KP, Chen HM, et al. Prevalence of headache in a Chinese elderly population in Kimmen: age and gender effect and cross-cultural comparisons. Neurology 1997, 48: 195–200.Google Scholar
  10. [10]
    Burnet PW, Harrison PJ, Goodwin GM, Battersby S, Ogilvie AD, Olesen J, et al. Allelic variation in the serotonin 5-HT2c receptor gene and migraine. Neuroreport 1997, 8: 2651–2653.PubMedCrossRefGoogle Scholar
  11. [11]
    Olesen J. The ischemic hypotheses of migraine. Arch Neurol 1987, 44: 321–322.PubMedGoogle Scholar
  12. [12]
    van der Kamp W, MaassenVanDenBrink A, Ferrari MD, van Dijk JG. Interictal cortical excitability to magnetic stimulation in familial hemiplegic migraine. Neurology 1997, 48: 1462–1464.PubMedGoogle Scholar
  13. [13]
    Nattero G, Allais G, De Lorenzo C, Torre E, Ancona M, Benedetto C, et al. Menstrual migraine: new biochemical and psychological aspects. Headache 1988, 28: 103–107.PubMedCrossRefGoogle Scholar
  14. [14]
    Edvardsen O, Dahl SG. Molecular structure and dynamics of 5-HT. Mol Brain Res 1991, 9: 31–37.PubMedCrossRefGoogle Scholar
  15. [15]
    Kitson SL. 5-Hydroxytryptamine (5-HT) receptor ligands. Curr Pharm Des 2007, 13: 2621–2637.PubMedCrossRefGoogle Scholar
  16. [16]
    Bhalla P, Sharma HS, Wurch T, Pauwels PJ, Saxena PR. Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptor. Br J Pharmacol 2000, 131: 949–957.PubMedCrossRefGoogle Scholar
  17. [17]
    Bao JZ, Ni CR, Zheng WQ. Age-related effects of estrogen on the expression of estrogen receptor alpha and beta mRNA in the ovariectomized monkey hypothalamus. Neurosci Bull 2006, 22: 97–102.PubMedGoogle Scholar
  18. [18]
    Ferrari MD, Odink J, Frölich M, Tapparelli C, Portielje JE. Release of platelet Met-enkephalin, but not serotonin, in migraine. A platelet response unique to migraine patients? J Neurol Sci 1989, 93: 51–60.PubMedCrossRefGoogle Scholar
  19. [19]
    Ulrich V, Russell MB, Ostergaard S, Olesen J. Analysis of 31 families with an apparently autosomal-dominant transmission of migraine with aura in the nuclear family. Am J Med Genet 1997, 74: 395–397.PubMedCrossRefGoogle Scholar
  20. [20]
    Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbio A, et al. A gene for familial hemiplegic migraine maps to chromosome 19, Nat Genet 1993, 5: 40–45.PubMedCrossRefGoogle Scholar
  21. [21]
    Chabriat H, Tournier-Lasserve E, Vahedi K, Leys D, Joutel A, Nibbio A, et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology 1995, 46: 1086–1091.Google Scholar
  22. [22]
    Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al. Mapping of a second locus for familial hemiplegic migraine to lq21–q23 and evidence of further heterogeneity. Ann Neurol 1997, 42: 885–890.PubMedCrossRefGoogle Scholar
  23. [23]
    Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 1997, 49: 1231–1238.PubMedGoogle Scholar
  24. [24]
    Monari L, Mochi M, Valentino ML, Arnaldi C, Cortelli P, De Monte A, et al. Searching for migraine genes: exclusion of 290 cM out of the whole human genome. Ital J Neurol Sci 1997, 18: 277–282.PubMedCrossRefGoogle Scholar
  25. [25]
    Russell MB, Diamant M, Nørby S. Genetic heterogeneity of migraine with and without aura in Danes cannot be explained by mutation in mtDNA nucleotide pair 11084. Acta Neurol Scand 1997, 96: 171–173.PubMedGoogle Scholar
  26. [26]
    Peroutka SJ. Dopamine and migraine. Neurology 1997, 48: 650–656.Google Scholar
  27. [27]
    Griffiths LR, Nyholt DR, Curtain RP, Goadsby PJ, Brimage PJ. Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology 1997, 49: 614–617.PubMedGoogle Scholar
  28. [28]
    Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, Veneziano L, et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 2001, 68: 759–764.PubMedCrossRefGoogle Scholar
  29. [29]
    Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366: 371–377.PubMedCrossRefGoogle Scholar
  30. [30]
    Wang XP, Sun BM. Heterotopia in cerebral cortex. Epilepsia 1995, 36(Supple 3): S240.Google Scholar
  31. [31]
    Beyenburg S, Watzka M, Blümcke I, Schramm J, Bidlingmaier F, Elger CE, et al. Expression of mRNAs encoding for 17betahydroxisteroid dehydrogenase isozymes 1, 2, 3 and 4 in epileptic human hippocampus. Epilepsy Res 2000, 41: 83–91.PubMedCrossRefGoogle Scholar
  32. [32]
    Wang XP. Migraine without aura: a sex-conditioned genetic model? J Neurol Sci 1997, 150(Supple 1): S169.CrossRefGoogle Scholar
  33. [33]
    Wang XP, Wang XH, Bao YC, Zhou JN. Apolipoprotien E genotypes in Chinese patients with Wilson’s disease. QJM 2003, 96: 541–542.PubMedCrossRefGoogle Scholar
  34. [34]
    Wang XP, Bao YC, Wang XH, Liu J, Zhou JN. ApoE genotype distribution in 32 Chinese patients with hepatolenticular degeneration. Chin J Neurosci 2003, 3: 186–189. (Chinese, English abstract)Google Scholar
  35. [35]
    Meyer JM, Han J, Moxley G. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis. Arthritis Rheum 2001, 44: 286–295.PubMedCrossRefGoogle Scholar
  36. [36]
    Low NC, Cui L, Merikangas KR. Sex differences in the transmission of migraine. Cephalalgia 2007, 27: 935–942.PubMedCrossRefGoogle Scholar
  37. [37]
    Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia 2000, 20: 3–14.PubMedCrossRefGoogle Scholar
  38. [38]
    Wessman M, Terwindt GM, Kaunisto MA, Palotie A, Ophoff RA. Migraine: a complex genetic disorder. Lancet Neurol 2007, 6: 521–532.PubMedCrossRefGoogle Scholar
  39. [39]
    Wang XP. Foundations in social neuroscience. Lancet Neurol 2003, 2: 515.CrossRefGoogle Scholar
  40. [40]
    Breslau N, Rasmussen BK. The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology 2001, 56(Supple 1): S4–S12.PubMedGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag GmbH 2008

Authors and Affiliations

  • Xiao-Ping Wang (王晓平)
    • 1
    Email author
  • Hong-Liu Ding (丁洪流)
    • 2
  • Chang-Ming Geng (耿昌明)
    • 1
  • Yu-Mei Jiang (蒋玉美)
    • 1
  1. 1.Department of Neurology, Shanghai First People’s HospitalShanghai Jiao-Tong UniversityShanghaiChina
  2. 2.Meyers Primary Care InstituteUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations